These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 14825808)

  • 1. [Parenteral administration of conteben and PAS].
    WILDE W
    Klin Wochenschr; 1951 Mar; 29(11-12):230-1. PubMed ID: 14825808
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experiments on combined therapeutic use of streptomycin, conteben and PAS; erythrocyte modifications due to conteben].
    MOESCHLIN S; DEMIRAL B
    Helv Med Acta; 1950 Oct; 17(4-5):568-71. PubMed ID: 14793861
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chemotherapy of tuberculosis with conteben and PAS].
    FRAHM H
    Z Tuberk; 1950; 96(1-2):5-14. PubMed ID: 14818387
    [No Abstract]   [Full Text] [Related]  

  • 4. [Conteben, PAS and streptomycin therapy of tuberculosis in children].
    BRUGGER H
    Munch Med Wochenschr; 1950 Aug; 92(19-20):738-46. PubMed ID: 14775621
    [No Abstract]   [Full Text] [Related]  

  • 5. [Reactions of the white blood picture during treatment with conteben and PAS].
    SCHUBERT H
    Tuberkulosearzt; 1950 Oct; 4(10):579-83. PubMed ID: 14788304
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative effect of conteben and PAS in pulmonary tuberculosis therapy].
    RAXELL R
    Sven Lakartidn; 1951 Aug; 48(31):1829-41. PubMed ID: 14866798
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect in vitro of conteben, streptomycin, and PAS on TB-VI-resistant tubercle bacilli].
    von VIETINGHOFF-SCHEEL O
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1951; 105(4):354-61. PubMed ID: 14847988
    [No Abstract]   [Full Text] [Related]  

  • 8. [Side effects of PAS and conteben therapy; reply to Dr. Erik Forsgren].
    BERGQVIST N; DE MARE O
    Sven Lakartidn; 1951 Nov; 48(47):2841-2. PubMed ID: 14922216
    [No Abstract]   [Full Text] [Related]  

  • 9. [Practical viewpoints of resistance against streptomycin, PAS, conteben].
    UNHOLTZ K
    Tuberkulosearzt; 1952 Aug; 6(8):451-9. PubMed ID: 13005732
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tubercle bacillus resistance and the drug blood level during conteben, PAS and streptomycin therapy of pulmonary tuberculosis].
    HOFMANN P; NICKEL L
    Tuberkulosearzt; 1950 Dec; 4(12):695-702. PubMed ID: 14809773
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on the concentration of PAS and TB 1 in the pleural effusion while undergoing respective treatment. II. On TB 1 (conteben)].
    KAWAI K
    Kekkaku; 1952 Aug; 27(8):397-401. PubMed ID: 13023835
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effective tuberculostatic minimal concentration of streptomycin, conteben, PAS and neoteben in vitro and resistance phenomenon].
    WEIDMANN S; SAAME H
    Z Hyg Infektionskr; 1953; 136(6):579-86. PubMed ID: 13103314
    [No Abstract]   [Full Text] [Related]  

  • 13. [Electron-microscopy of the effect of streptomycin, PAS, conteben, and solvoteben on the development of Mycobacterium avium chester].
    BRINGMANN G
    Z Hyg Infektionskr; 1952; 135(6):505-25. PubMed ID: 13039362
    [No Abstract]   [Full Text] [Related]  

  • 14. [Further experience with streptomycin, PAS and TB I (Conteben) in the treatment of internal tuberculosis].
    HEILMEYER L
    Dtsch Med Wochenschr; 1950 Apr; 75(15):473-7. PubMed ID: 15421111
    [No Abstract]   [Full Text] [Related]  

  • 15. [A possible antidiuretic effect of thiosemicarbazone (conteben) resembling that of caronamide].
    BOHM F
    Klin Wochenschr; 1950 Dec; 28(45-46):779-80. PubMed ID: 14805002
    [No Abstract]   [Full Text] [Related]  

  • 16. [Resistance determination of tubercle bacteria against streptomycin, PAS, conteben, isoniazid and paratebin].
    VON VIETINGHOFF-SCHEEL O
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1953; 108(6):490-501. PubMed ID: 13081562
    [No Abstract]   [Full Text] [Related]  

  • 17. [Resorption of conteben and p-aminosalicylic acid following intracavitary instillation].
    WILDE W; RUCK KH
    Med Monatsschr; 1950 Aug; 4(8):601-3. PubMed ID: 15438651
    [No Abstract]   [Full Text] [Related]  

  • 18. [Considerations on a case of tuberculous meningitis treated with thiosemicarbazone (conteben), dihydrostreptomycin and paraaminosalicylic acid (paracipan)].
    SAGUES L
    Dia Med; 1953 Apr; 25(19):461-2. PubMed ID: 13052026
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypothyroidism and cerebral edema following combined treatment of tuberculosis with conteben (TB I 698) and p-amino-salicylic acid.
    BERGQVIST N; DE MARE O
    Acta Med Scand; 1952 Aug; 143(5):323-35. PubMed ID: 12976024
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative research on the results of ambulatory treatment of pulmonary tuberculosis with conteben/pasalon, respectively isonicotinic acid hydrazide].
    MEESE T
    Z Tuberk; 1955; 106(4-5):272-6. PubMed ID: 13300652
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.